Redfield Robert has filed 5 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 108854 shares of Traws Pharma, Inc. ($TRAW) on March 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 8, 2026 | Traws Pharma, Inc. | $TRAW | Redfield Robert | Chief Medical Officer | A | Stock Option (right to buy) | 108854 | $0.00 | 108,854.0000 | 8,818,859 | 9999.99% | 1.23% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Redfield Robert | Chief Medical Officer | A | Common Stock | 16419 | $0.00 | 113,919.0000 | 8,818,859 | 16.84% | 0.19% |
| Dec. 12, 2025 | Traws Pharma, Inc. | $TRAW | Redfield Robert | Chief Medical Officer | A | Stock Option (right to purchase) | 65676 | $0.00 | 65,676.0000 | 8,818,859 | 9999.99% | 0.74% |
| Oct. 12, 2025 | Traws Pharma, Inc. | $TRAW | Redfield Robert | Chief Medical Officer | A | Stock Option (right to purchase) | 32406 | $0.00 | 32,406.0000 | 8,818,859 | 9999.99% | 0.37% |
| April 1, 2024 | Traws Pharma, Inc. | $TRAW | Redfield Robert | Acting Chief Medical Officer | A | Common Stock | 97500 | $0.00 | 97,500.0000 | 841,738 | 9999.99% | 11.58% |